Kent SJ - Search Results

1

A multifunctional human monoclonal neutralizing antibody that targets a unique conserved epitope on influenza HA.

Bangaru S, Zhang H, Gilchuk IM, Voss TG, Irving RP, Gilchuk P, Matta P, Zhu X, Lang S, Nieusma T, Richt JA, Albrecht RA, Vanderven HA, Bombardi R, Kent SJ, Ward AB, Wilson IA, Crowe JE Jr. Bangaru S, et al. Among authors: kent sj. Nat Commun. 2018 Jul 10;9(1):2669. doi: 10.1038/s41467-018-04704-9. Nat Commun. 2018. PMID: 29991715 Free PMC article.

2

HIV Vaccine efficacy trial: glimmers of hope and the potential role of antibody-dependent cellular cytotoxicity.

Wren L, Kent SJ. Wren L, et al. Among authors: kent sj. Hum Vaccin. 2011 Apr;7(4):466-73. doi: 10.4161/hv.7.4.14123. Epub 2011 Apr 1. Hum Vaccin. 2011. PMID: 21389779 Review.

3

HIV-specific antibody-dependent cellular cytotoxicity: a novel vaccine modality.

Madhavi V, Kent SJ, Stratov I. Madhavi V, et al. Among authors: kent sj. Expert Rev Clin Immunol. 2012 Nov;8(8):767-74. doi: 10.1586/eci.12.74. Expert Rev Clin Immunol. 2012. PMID: 23167688 Review.

4

Cross-reactive influenza-specific antibody-dependent cellular cytotoxicity antibodies in the absence of neutralizing antibodies.

Jegaskanda S, Job ER, Kramski M, Laurie K, Isitman G, de Rose R, Winnall WR, Stratov I, Brooks AG, Reading PC, Kent SJ. Jegaskanda S, et al. Among authors: kent sj. J Immunol. 2013 Feb 15;190(4):1837-48. doi: 10.4049/jimmunol.1201574. Epub 2013 Jan 14. J Immunol. 2013. PMID: 23319732

5

Antibody-dependent cellular cytotoxicity is associated with control of pandemic H1N1 influenza virus infection of macaques.

Jegaskanda S, Weinfurter JT, Friedrich TC, Kent SJ. Jegaskanda S, et al. Among authors: kent sj. J Virol. 2013 May;87(10):5512-22. doi: 10.1128/JVI.03030-12. Epub 2013 Mar 6. J Virol. 2013. PMID: 23468501 Free PMC article.

6

Age-associated cross-reactive antibody-dependent cellular cytotoxicity toward 2009 pandemic influenza A virus subtype H1N1.

Jegaskanda S, Laurie KL, Amarasena TH, Winnall WR, Kramski M, De Rose R, Barr IG, Brooks AG, Reading PC, Kent SJ. Jegaskanda S, et al. Among authors: kent sj. J Infect Dis. 2013 Oct 1;208(7):1051-61. doi: 10.1093/infdis/jit294. Epub 2013 Jun 28. J Infect Dis. 2013. PMID: 23812238

7

Standard trivalent influenza virus protein vaccination does not prime antibody-dependent cellular cytotoxicity in macaques.

Jegaskanda S, Amarasena TH, Laurie KL, Tan HX, Butler J, Parsons MS, Alcantara S, Petravic J, Davenport MP, Hurt AC, Reading PC, Kent SJ. Jegaskanda S, et al. Among authors: kent sj. J Virol. 2013 Dec;87(24):13706-18. doi: 10.1128/JVI.01666-13. Epub 2013 Oct 9. J Virol. 2013. PMID: 24109221 Free PMC article.

8

Toward improved influenza vaccines.

Kent SJ. Kent SJ. J Infect Dis. 2014 Jan 1;209(1):4-5. doi: 10.1093/infdis/jit542. Epub 2013 Oct 17. J Infect Dis. 2014. PMID: 24141981 No abstract available.

9

Cross-reactive influenza-specific antibody-dependent cellular cytotoxicity in intravenous immunoglobulin as a potential therapeutic against emerging influenza viruses.

Jegaskanda S, Vandenberg K, Laurie KL, Loh L, Kramski M, Winnall WR, Kedzierska K, Rockman S, Kent SJ. Jegaskanda S, et al. Among authors: kent sj. J Infect Dis. 2014 Dec 1;210(11):1811-22. doi: 10.1093/infdis/jiu334. Epub 2014 Jun 10. J Infect Dis. 2014. PMID: 24916185

10

Influenza-specific antibody-dependent cellular cytotoxicity: toward a universal influenza vaccine.

Jegaskanda S, Reading PC, Kent SJ. Jegaskanda S, et al. Among authors: kent sj. J Immunol. 2014 Jul 15;193(2):469-75. doi: 10.4049/jimmunol.1400432. J Immunol. 2014. PMID: 24994909 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

417 results

Search Page